Observational study on pregnancy and future health outcomes
Official title: Pregnancy Cohort Study: Pregnancy as a Window to Future Health
Run by Medical University of Graz · NCT06925815 · Data updated 2026-11-12
This study looks at how conditions like obesity and gestational diabetes during pregnancy affect the health of both mothers and their babies now and in the future.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 800 (estimated) |
| Sponsor | Medical University of Graz Academic / other |
| Locations | 1 site (Graz, Styria) |
| Status | Recruiting |
| Started | July 27, 2023 |
| Main results expected | June 2033 |
| Study ends | June 2034 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT06925815 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women who are less than 14 weeks gestation and are over 18 years old.
✕Probably not a fit
Patients who are beyond 14 weeks of gestation or have fetal genetic anomalies will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study aims to explore how metabolic disorders such as obesity and gestational diabetes during pregnancy influence both maternal and fetal health in the short and long term. It will assess various factors including pregnancy outcomes, fetal growth, newborn metabolism, breast milk composition, and maternal health post-delivery. Pregnant women will participate in multiple clinic visits throughout their pregnancy and shortly after childbirth to undergo physical examinations and assessments. The study seeks to identify potential preventive measures that could mitigate adverse health trajectories for both mothers and their children.
Why it matters
Potential benefit: If successful, this study could lead to improved health outcomes for mothers and their children by identifying effective interventions during pregnancy.
How similar studies have gone: Other studies have shown success in understanding the impact of maternal health on pregnancy outcomes, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ongoing pregnancy prior to 14th gestational week, women with child wish; above 18 years of age, giving informed consent Exclusion Criteria: * gestational age \> 14th week of gestation; below 18 years of age; fetal genetic anomalies /malformation
Where it's running
-
Department of Obstetrics and Gynecology, Medical University of Graz
Graz, Styria, Austria Recruiting
Study contacts
- Principal investigator: Evelyn Jantscher-Krenn, PhD — Medical University of Graz
- Study coordinator: Evelyn Jantscher-Krenn, PhD
- Email: evelyn.jantscher-krenn@medunigraz.at
- Phone: +43 316 385 80076
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early Glucose Patterns in Pregnant Women at Risk for GDM
This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.
-
Probiotic-augmented therapy for gestational diabetes
This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
How sleep, lifestyle, and metabolism relate to pregnancy outcomes in gestational diabetes
This project will see if sleep quality, anxiety, eating and activity habits, and metabolic markers relate to blood sugar control and birth outcomes in pregnant people with gestational diabetes.
-
Hope‑D digital weight management program for pregnancy and the first six months after birth
This test tries the Hope‑D digital weight management program with pregnant women who had a pre-pregnancy BMI of 30 or higher to support weight during pregnancy and through six months postpartum.
-
Pre-eclampsia risk in pregnancies after oocyte donation
We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.